These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37667954)

  • 1. Prevention of recurrent respiratory tract infections: a literature review of the activity of the bacterial lysate Lantigen B.
    Braido F; Melioli G; Nicolini G; Canonica GW
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7756-7767. PubMed ID: 37667954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial.
    Braido F; Melioli G; Candoli P; Cavalot A; Di Gioacchino M; Ferrero V; Incorvaia C; Mereu C; Ridolo E; Rolla G; Rossi O; Savi E; Tubino L; Reggiardo G; Baiardini I; di Marco E; Rinaldi G; Canonica GW; ; Accorsi C; Bossilino C; Bonzano L; DiLizia M; Fedrighini B; Garelli V; Gerace V; Maniscalco S; Massaro I; Messi A; Milanese M; Peveri S; Penno A; Pizzimenti S; Pozzo T; Raie A; Regina S; Sclifò F
    Immunol Lett; 2014 Dec; 162(2 Pt B):185-93. PubMed ID: 25445613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Lantigen B in the prevention of bacterial respiratory infections.
    Pozzi E; Serra C
    Monaldi Arch Chest Dis; 2004; 61(1):19-27. PubMed ID: 15366332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis.
    Cazzola M; Anapurapu S; Page CP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):62-8. PubMed ID: 22155205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of sublingual polyvalent bacterial vaccine (Lantigen B) in children with recurrent respiratory infection: a randomized double-blind controlled clinical trial].
    Chen AH; Chen RC; Zhang CQ; Chen D; Huang S; Lin Y; Zhan J; Zhong N
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):463-4. PubMed ID: 15265442
    [No Abstract]   [Full Text] [Related]  

  • 7. Probiotics for preventing acute upper respiratory tract infections.
    Zhao Y; Dong BR; Hao Q
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD006895. PubMed ID: 36001877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oropharyngeal Probiotic ENT-K12 as an Effective Dietary Intervention for Children With Recurrent Respiratory Tract Infections During Cold Season.
    Guo H; Xiang X; Lin X; Wang Q; Qin S; Lu X; Xu J; Fang Y; Liu Y; Cui J; Li Z
    Front Nutr; 2022; 9():900448. PubMed ID: 35634421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation.
    Minozzi S; Pifferi S; Brazzi L; Pecoraro V; Montrucchio G; D'Amico R
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD000022. PubMed ID: 33481250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and tolerability of an immune-stimulant(*) constituted by inactivated bacterial bodies in the prophylaxis of infectious episodes of airways: a double blind, placebo-controlled, randomized, multicentre study.
    Carlone S; Minenna M; Morlino P; Mosca L; Pasqua F; Pela R; Schino P; Tubaldi A; Tupputi E; De Benedetto F;
    Multidiscip Respir Med; 2014; 9(1):58. PubMed ID: 25699178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for preventing infection in nephrotic syndrome.
    Wu HM; Tang JL; Cao L; Sha ZH; Li Y
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003964. PubMed ID: 22513919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections.
    Macchi A; Vecchia LD
    Arzneimittelforschung; 2005; 55(5):276-81. PubMed ID: 15960427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
    Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
    Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term antibiotics for preventing recurrent urinary tract infection in children.
    Williams G; Craig JC
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001534. PubMed ID: 30932167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological profiles of children with recurrent otitis media with or without spontaneous tympanic membrane perforation and of children with recurrent respiratory infections.
    Torretta S; Rosazza C; Baselli L; Berti C; Bosi P; Dellepiane RM; Folino F; Milani GP; Marchisio P
    Int J Pediatr Otorhinolaryngol; 2022 Sep; 160():111219. PubMed ID: 35835031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant impact of recurrent respiratory tract infections in children with Down syndrome.
    Verstegen RH; van Gameren-Oosterom HB; Fekkes M; Dusseldorp E; de Vries E; van Wouwe JP
    Child Care Health Dev; 2013 Nov; 39(6):801-9. PubMed ID: 22774862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections.
    Esposito S; Bianchini S; Bosis S; Tagliabue C; Coro I; Argentiero A; Principi N
    J Transl Med; 2019 Aug; 17(1):284. PubMed ID: 31443716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study.
    Gulliford MC; Juszczyk D; Prevost AT; Soames J; McDermott L; Sultana K; Wright M; Fox R; Hay AD; Little P; Moore M; Yardley L; Ashworth M; Charlton J
    Health Technol Assess; 2019 Mar; 23(11):1-70. PubMed ID: 30900550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.